Bad Berka Heart Rhythm Registry for people with or at risk of heart rhythm problems treated at Heart Center Bad Berka
The Bad Berka Heart Rhythm Registry (2B2R) is a Prospective, Single-center Observational Cohort Evaluating Safety, Efficacy, and Outcomes in Patients Undergoing Arrhythmia Therapy or CIED Implantation at the Heart Center Bad Berka
This registry will collect information from adults with or at risk of heart rhythm problems treated at the Heart Center Bad Berka to see which treatments, devices, and technologies work best and are safest.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Zentralklinik Bad Berka Academic / other |
| Locations | 1 site (Bad Berka) |
| Trial ID | NCT07020910 on ClinicalTrials.gov |
What this trial studies
The Bad Berka Heart Rhythm Registry is a prospective, single-center observational cohort that will systematically collect clinical, procedural, imaging, device, and patient-reported data from adults treated for cardiac arrhythmias at Heart Center Bad Berka. Data collected will include procedural parameters, acute success, complication rates, device therapy details, and standardized follow-up outcomes, with planned substudies on technologies such as pulsed field ablation, high-density mapping, and conduction system or device-based therapies. The registry will capture patients undergoing medical therapy, electrophysiology studies, catheter ablation, interventional stroke-prevention, and cardiac electronic device implantation. Analyses will seek predictors of outcomes and complications, compare procedural strategies, and generate real-world evidence to support clinical decision-making and quality assurance.
Who should consider this trial
Good fit: Adults (18 and older) with documented or suspected cardiac arrhythmias who are receiving medical or interventional therapy or device implantation at Heart Center Bad Berka and can give informed consent are eligible.
Not a fit: Patients who cannot provide informed consent, who are enrolled in an incompatible interventional trial, or who are treated outside the center are unlikely to derive direct benefit from participation.
Why it matters
Potential benefit: If successful, the registry could help clinicians choose safer and more effective arrhythmia treatments and device strategies by providing real-world outcome data.
How similar studies have performed: Other large electrophysiology registries have provided valuable real-world safety and effectiveness data, though approaches like pulsed field ablation and conduction system pacing remain relatively newer and less extensively characterized in registries.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years * At risk of or with documented cardiac arrhythmia undergoing medical or interventional therapy at the Heart Center Bad Berka * Informed consent obtained Exclusion Criteria: * Inability or unwillingness to provide informed consent * Participation in another interventional trial that precludes registry inclusion
Where this trial is running
Bad Berka
- Zentralklinik Bad Berka — Bad Berka, Germany (Recruiting)
Study contacts
- Study coordinator: Christoph Geller, Prof. Dr. med.
- Email: kar@zentralklinik.de
- Phone: +49 (0) 36458 5-1201 / 1205
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.